{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T12:06:52Z","timestamp":1792325212888,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.hpb.2023.05.003","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T21:10:09Z","timestamp":1683580209000},"page":"1074-1082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Surgical debulking is associated with improved survival for patients with neuroendocrine liver metastases of unknown primary"],"prefix":"10.1016","volume":"25","author":[{"given":"Samantha M.","family":"Ruff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0298-6913","authenticated-orcid":false,"given":"Dane A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha L.","family":"Lad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Anantha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle K.","family":"DePeralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2501-0235","authenticated-orcid":false,"given":"Gary B.","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2023.05.003_bib1","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1093\/annonc\/mdt377","article-title":"Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n\u00a0= 25 531)","volume":"24","author":"Mocellin","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2023.05.003_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hpb.2023.05.003_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000504370","article-title":"Diagnostic approaches to neuroendocrine neoplasms of unknown primary site","volume":"110","author":"Berner","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.hpb.2023.05.003_bib4","first-page":"276","article-title":"Identification of unknown primary tumors in patients with neuroendocrine liver metastases","volume":"145","author":"Wang","year":"2010","journal-title":"Arch Surg Chic Ill 1960"},{"key":"10.1016\/j.hpb.2023.05.003_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.surg.2016.05.055","article-title":"Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors","volume":"161","author":"Keck","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.05.003_bib6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1477-2574.2010.00198.x","article-title":"Long-term survival after surgical management of neuroendocrine hepatic metastases","volume":"12","author":"Glazer","year":"2010","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2023.05.003_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.surg.2015.03.033","article-title":"Net health benefit of hepatic resection versus intraarterial therapies for neuroendocrine liver metastases: a Markov decision model","volume":"158","author":"Spolverato","year":"2015","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.05.003_bib8","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1245\/s10434-018-6518-2","article-title":"Recurrence of pancreatic neuroendocrine tumors and survival predicted by Ki67","volume":"25","author":"Gen\u00e7","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2023.05.003_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.surg.2012.02.011","article-title":"Ki-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine tumors","volume":"152","author":"Hamilton","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.05.003_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.hpb.2023.05.003_bib11","article-title":"Primary tumor site affects survival in patients with gastroenteropancreatic and neuroendocrine liver metastases","volume":"2019","author":"Tierney","year":"2019","journal-title":"Internet J Endocrinol"},{"key":"10.1016\/j.hpb.2023.05.003_bib12","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2023.05.003_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000443170","article-title":"ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum","volume":"103","author":"Niederle","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.hpb.2023.05.003_bib14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A\u00a05-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2023.05.003_bib15","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.surg.2014.08.009","article-title":"Expanded criteria for carcinoid liver debulking: maintaining survival and increasing the number of eligible patients","volume":"156","author":"Graff-Baker","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.05.003_bib16","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.surg.2014.08.008","article-title":"A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors","volume":"156","author":"Maxwell","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.05.003_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.surg.2018.04.070","article-title":"Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs)","volume":"165","author":"Scott","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.05.003_bib18","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.3748\/wjg.v24.i24.2640","article-title":"Primary hepatic neuroendocrine tumor case with a preoperative course of 26 years: a case report and literature review","volume":"24","author":"Meng","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2023.05.003_bib19","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1245\/s10434-020-08787-x","article-title":"The landmark series: neuroendocrine tumor liver metastases","volume":"27","author":"Gangi","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2023.05.003_bib20","doi-asserted-by":"crossref","first-page":"44051","DOI":"10.21037\/hbsn.2020.04.02","article-title":"Neuroendocrine liver metastases: a contemporary review of treatment strategies","volume":"9","author":"Cloyd","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.hpb.2023.05.003_bib21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.6004\/jnccn.2021.0032","article-title":"Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in Oncology","volume":"19","author":"Shah","year":"2021","journal-title":"J\u00a0Natl Compr Cancer Netw JNCCN"},{"key":"10.1016\/j.hpb.2023.05.003_bib22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jamasurg.2014.216","article-title":"Neuroendocrine tumors of unknown primary: is the primary site really not known?","volume":"149","author":"Bergsland","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hpb.2023.05.003_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jso.24563","article-title":"Neuroendocrine liver metastasis: the chance to be cured after liver surgery","volume":"115","author":"Bagante","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2023.05.003_bib24","first-page":"1","article-title":"Solid liver tumors","volume":"22","author":"Foster","year":"1977","journal-title":"Major Probl Clin Surg"},{"key":"10.1016\/j.hpb.2023.05.003_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0011-3840(81)80009-3","article-title":"Liver metastases","volume":"18","author":"Foster","year":"1981","journal-title":"Curr Probl Surg"},{"key":"10.1016\/j.hpb.2023.05.003_bib26","first-page":"1091","article-title":"Cytoreductive hepatic surgery for neuroendocrine tumors","volume":"108","author":"McEntee","year":"1990","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.05.003_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0002-9610(99)80107-X","article-title":"Hepatic resection for metastatic neuroendocrine carcinomas","volume":"169","author":"Que","year":"1995","journal-title":"Am J Surg"},{"key":"10.1016\/j.hpb.2023.05.003_bib28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.surg.2008.06.008","article-title":"The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors","volume":"144","author":"Chambers","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.05.003_bib29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.surg.2017.05.030","article-title":"Expanded criteria for debulking of liver metastasis also apply to pancreatic neuroendocrine tumors","volume":"163","author":"Morgan","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.05.003_bib30","first-page":"1239","article-title":"Relationship between primary tumor resection for metastatic small intestine neuroendocrine tumors and survival: a propensity score-matched analysis","volume":"35","author":"Yan","year":"2022","journal-title":"J\u00a0Investig Surg Off J Acad Surg Res"},{"key":"10.1016\/j.hpb.2023.05.003_bib31","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1245\/s10434-010-1154-5","article-title":"Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis","volume":"17","author":"Mayo","year":"2010","journal-title":"Ann Surg Oncol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X23001417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X23001417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:41:41Z","timestamp":1761266501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X23001417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1365182X23001417"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2023.05.003","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical debulking is associated with improved survival for patients with neuroendocrine liver metastases of unknown primary","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2023.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}